Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Equity: 2017-2024

Historic Return on Equity for Organogenesis Holdings (ORGO) over the last 8 years, with Dec 2024 value amounting to -0.04%.

  • Organogenesis Holdings' Return on Equity fell 1.00% to -0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.04%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of -0.04% for FY2024, which is 5.00% down from last year.
  • Per Organogenesis Holdings' latest filing, its Return on Equity stood at -0.04% for FY2024, which was down 300.37% from 0.02% recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Return on Equity ranged from a high of 0.49% in FY2021 and a low of -0.04% during FY2024.
  • Its 3-year average for Return on Equity is 0.01%, with a median of 0.02% in 2023.
  • Per our database at Business Quant, Organogenesis Holdings' Return on Equity surged by 131bps in 2020 and then slumped by 43bps in 2022.
  • Yearly analysis of 5 years shows Organogenesis Holdings' Return on Equity stood at 0.17% in 2020, then surged by 32bps to 0.49% in 2021, then crashed by 43bps to 0.06% in 2022, then declined by 4bps to 0.02% in 2023, then declined by 5bps to -0.04% in 2024.